Publication | Open Access
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases
64
Citations
33
References
2020
Year
The use of systemic immunosuppression was not associated with an increased risk of COVID-19 in a multi-institutional cohort of patients with IBD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1